ASP Isotopes vs Jaguar Health
ASPI and JAGX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASPI and JAGX compare
ASP Isotopes is the larger company, worth 104 times as much as Jaguar Health ($210M against $2.0M).
ASP Isotopes grew revenue faster over the last twelve months (573% versus 136% for Jaguar Health).
ASP Isotopes scores higher on the StockData Score (6 against 3 for Jaguar Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASPI | JAGX |
|---|---|---|
| Size and price | ||
| Market cap | $210M | $2.0M |
| Share price | $1.37 | $0.390 |
| Change, 1 year | −83.1% | −100.0% |
| Change, 5 years | – | −100% |
| Beta (5Y) | 3.00 | 5.30 |
| Employees | 271 | 47 |
| StockData Score | ||
| Total score | 6 (better) | 3 |
| Valuation score | 3 (better) | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 2 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 6.8× | 0.1× (better) |
| P/B | 0.8× | – |
| FCF yield | −39.8% | – |
| Fair value | $5.20 | – |
| Margin of safety | 73.7% | – |
| Growth | ||
| Revenue growth (TTM) | 573% (better) | 136% |
| Revenue growth, 5Y average | – | 4.2% |
| Profitability | ||
| Gross margin | 18.3% | 82.3% (better) |
| Operating margin | −321% | −93.1% (better) |
| Net margin | −380% | – |
| FCF margin | −271% | – |
| Return on equity | −80.9% | – |
| Return on invested capital | −549% | – |
| Financial health | ||
| Debt / equity | 0.23 | – |
| Interest coverage | −25.3× (better) | −25.9× |
| Current ratio | 3.87 (better) | 0.69 |
| Altman Z-score | −0.34 (better) | −18.45 |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 42.7% | – |
| Held by insiders | 10.7% | 17.1% |
| Insider net buying, 12 months | −$7.7M | – |
| Short interest, % of float | 22.9% | 4.7% |
Go deeper
- ASPI stock overview
- ASPI income statement
- ASPI valuation and score
- JAGX stock overview
- JAGX income statement
- JAGX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.